Predicting the molecular subtypes of 2021 WHO grade 4 glioma by a multiparametric MRI-based machine learning model
Abstract Background Accurately distinguishing the different molecular subtypes of 2021 World Health Organization (WHO) grade 4 Central Nervous System (CNS) gliomas is highly relevant for prognostic stratification and personalized treatment. Objectives To develop and validate a machine learning (ML)...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14529-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849343646630936576 |
|---|---|
| author | Wenji Xu Yangyang Li Jie Zhang Zhiyi Zhang Pengxin Shen Xiaochun Wang Guoqiang Yang Jiangfeng Du Hui Zhang Yan Tan |
| author_facet | Wenji Xu Yangyang Li Jie Zhang Zhiyi Zhang Pengxin Shen Xiaochun Wang Guoqiang Yang Jiangfeng Du Hui Zhang Yan Tan |
| author_sort | Wenji Xu |
| collection | DOAJ |
| description | Abstract Background Accurately distinguishing the different molecular subtypes of 2021 World Health Organization (WHO) grade 4 Central Nervous System (CNS) gliomas is highly relevant for prognostic stratification and personalized treatment. Objectives To develop and validate a machine learning (ML) model using multiparametric MRI for the preoperative differentiation of astrocytoma, CNS WHO grade 4, and glioblastoma (GBM), isocitrate dehydrogenase-wild-type (IDH-wt) (WHO 2021) (Task 1:grade 4 vs. GBM); and to stratify astrocytoma, CNS WHO grade 4, by distinguish astrocytoma, IDH-mutant (IDH-mut), CNS WHO grade 4 from astrocytoma, IDH-wild-type (IDH-wt), CNS WHO grade 4 (Task 2:IDH-mut grade 4 vs. IDH-wt grade 4). Additionally, to evaluate the model’s prognostic value. Methods We retrospectively analyzed 320 glioma patients from three hospitals (training/testing, 7:3 ratio) and 99 patients from The Cancer Genome Atlas (TCGA) database for external validation. Radiomic features were extracted from tumor and edema on contrast-enhanced T1-weighted imaging (CE-T1WI) and T2 fluid-attenuated inversion recovery (T2-FLAIR). Extreme gradient boosting (XGBoost) was utilized for constructing the ML, clinical, and combined models. Model performance was evaluated with receiver operating characteristic (ROC) curves, decision curves, and calibration curves. Stability was evaluated using six additional classifiers. Kaplan-Meier (KM) survival analysis and the log-rank test assessed the model’s prognostic value. Results In Task 1 and Task 2, the combined model (AUC = 0.907, 0.852 and 0.830 for Task 1; AUC = 0.899, 0.895 and 0.792 for Task 2) and the optimal ML model (AUC = 0.902, 0.854 and 0.832 for Task 1; AUC = 0.904, 0.899 and 0.783 for Task 2) significantly outperformed the clinical model (AUC = 0.671, 0.656, and 0.543 for Task 1; AUC = 0.619, 0.605 and 0.400 for Task 2) in both the training, testing and validation sets. Survival analysis showed the combined model performed similarly to molecular subtype in both tasks (p = 0.964 and p = 0.746). Conclusion The multiparametric MRI ML model effectively distinguished astrocytoma, CNS WHO grade 4 from GBM, IDH-wt (WHO 2021) and differentiated astrocytoma, IDH-mut from astrocytoma, IDH-wt, CNS WHO grade 4. Additionally, the model provided reliable survival stratification for glioma patients across different molecular subtypes. |
| format | Article |
| id | doaj-art-7e422252d41d406592e8a8db7b3e9783 |
| institution | Kabale University |
| issn | 1471-2407 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cancer |
| spelling | doaj-art-7e422252d41d406592e8a8db7b3e97832025-08-20T03:42:53ZengBMCBMC Cancer1471-24072025-07-0125111610.1186/s12885-025-14529-7Predicting the molecular subtypes of 2021 WHO grade 4 glioma by a multiparametric MRI-based machine learning modelWenji Xu0Yangyang Li1Jie Zhang2Zhiyi Zhang3Pengxin Shen4Xiaochun Wang5Guoqiang Yang6Jiangfeng Du7Hui Zhang8Yan Tan9College of Medical Imaging, Shanxi Medical UniversityCollege of Medical Imaging, Shanxi Medical UniversityCollege of Medical Imaging, Shanxi Medical UniversityCollege of Medical Imaging, Shanxi Medical UniversityCollege of Medical Imaging, Shanxi Medical UniversityDepartment of Radiology, First Hospital of Shanxi Medical UniversityDepartment of Radiology, First Hospital of Shanxi Medical UniversityDepartment of Radiology, First Hospital of Shanxi Medical UniversityDepartment of Radiology, First Hospital of Shanxi Medical UniversityDepartment of Radiology, First Hospital of Shanxi Medical UniversityAbstract Background Accurately distinguishing the different molecular subtypes of 2021 World Health Organization (WHO) grade 4 Central Nervous System (CNS) gliomas is highly relevant for prognostic stratification and personalized treatment. Objectives To develop and validate a machine learning (ML) model using multiparametric MRI for the preoperative differentiation of astrocytoma, CNS WHO grade 4, and glioblastoma (GBM), isocitrate dehydrogenase-wild-type (IDH-wt) (WHO 2021) (Task 1:grade 4 vs. GBM); and to stratify astrocytoma, CNS WHO grade 4, by distinguish astrocytoma, IDH-mutant (IDH-mut), CNS WHO grade 4 from astrocytoma, IDH-wild-type (IDH-wt), CNS WHO grade 4 (Task 2:IDH-mut grade 4 vs. IDH-wt grade 4). Additionally, to evaluate the model’s prognostic value. Methods We retrospectively analyzed 320 glioma patients from three hospitals (training/testing, 7:3 ratio) and 99 patients from The Cancer Genome Atlas (TCGA) database for external validation. Radiomic features were extracted from tumor and edema on contrast-enhanced T1-weighted imaging (CE-T1WI) and T2 fluid-attenuated inversion recovery (T2-FLAIR). Extreme gradient boosting (XGBoost) was utilized for constructing the ML, clinical, and combined models. Model performance was evaluated with receiver operating characteristic (ROC) curves, decision curves, and calibration curves. Stability was evaluated using six additional classifiers. Kaplan-Meier (KM) survival analysis and the log-rank test assessed the model’s prognostic value. Results In Task 1 and Task 2, the combined model (AUC = 0.907, 0.852 and 0.830 for Task 1; AUC = 0.899, 0.895 and 0.792 for Task 2) and the optimal ML model (AUC = 0.902, 0.854 and 0.832 for Task 1; AUC = 0.904, 0.899 and 0.783 for Task 2) significantly outperformed the clinical model (AUC = 0.671, 0.656, and 0.543 for Task 1; AUC = 0.619, 0.605 and 0.400 for Task 2) in both the training, testing and validation sets. Survival analysis showed the combined model performed similarly to molecular subtype in both tasks (p = 0.964 and p = 0.746). Conclusion The multiparametric MRI ML model effectively distinguished astrocytoma, CNS WHO grade 4 from GBM, IDH-wt (WHO 2021) and differentiated astrocytoma, IDH-mut from astrocytoma, IDH-wt, CNS WHO grade 4. Additionally, the model provided reliable survival stratification for glioma patients across different molecular subtypes.https://doi.org/10.1186/s12885-025-14529-7AstrocytomaGlioblastomaMagnetic resonance imagingMachine learningMolecular subtype |
| spellingShingle | Wenji Xu Yangyang Li Jie Zhang Zhiyi Zhang Pengxin Shen Xiaochun Wang Guoqiang Yang Jiangfeng Du Hui Zhang Yan Tan Predicting the molecular subtypes of 2021 WHO grade 4 glioma by a multiparametric MRI-based machine learning model BMC Cancer Astrocytoma Glioblastoma Magnetic resonance imaging Machine learning Molecular subtype |
| title | Predicting the molecular subtypes of 2021 WHO grade 4 glioma by a multiparametric MRI-based machine learning model |
| title_full | Predicting the molecular subtypes of 2021 WHO grade 4 glioma by a multiparametric MRI-based machine learning model |
| title_fullStr | Predicting the molecular subtypes of 2021 WHO grade 4 glioma by a multiparametric MRI-based machine learning model |
| title_full_unstemmed | Predicting the molecular subtypes of 2021 WHO grade 4 glioma by a multiparametric MRI-based machine learning model |
| title_short | Predicting the molecular subtypes of 2021 WHO grade 4 glioma by a multiparametric MRI-based machine learning model |
| title_sort | predicting the molecular subtypes of 2021 who grade 4 glioma by a multiparametric mri based machine learning model |
| topic | Astrocytoma Glioblastoma Magnetic resonance imaging Machine learning Molecular subtype |
| url | https://doi.org/10.1186/s12885-025-14529-7 |
| work_keys_str_mv | AT wenjixu predictingthemolecularsubtypesof2021whograde4gliomabyamultiparametricmribasedmachinelearningmodel AT yangyangli predictingthemolecularsubtypesof2021whograde4gliomabyamultiparametricmribasedmachinelearningmodel AT jiezhang predictingthemolecularsubtypesof2021whograde4gliomabyamultiparametricmribasedmachinelearningmodel AT zhiyizhang predictingthemolecularsubtypesof2021whograde4gliomabyamultiparametricmribasedmachinelearningmodel AT pengxinshen predictingthemolecularsubtypesof2021whograde4gliomabyamultiparametricmribasedmachinelearningmodel AT xiaochunwang predictingthemolecularsubtypesof2021whograde4gliomabyamultiparametricmribasedmachinelearningmodel AT guoqiangyang predictingthemolecularsubtypesof2021whograde4gliomabyamultiparametricmribasedmachinelearningmodel AT jiangfengdu predictingthemolecularsubtypesof2021whograde4gliomabyamultiparametricmribasedmachinelearningmodel AT huizhang predictingthemolecularsubtypesof2021whograde4gliomabyamultiparametricmribasedmachinelearningmodel AT yantan predictingthemolecularsubtypesof2021whograde4gliomabyamultiparametricmribasedmachinelearningmodel |